These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28643153)

  • 1. A 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic Colorectal Cancer Model.
    Gong L; Ding H; Long NE; Sullivan BJ; Martin EW; Magliery TJ; Tweedle MF
    Mol Imaging Biol; 2018 Feb; 20(1):47-54. PubMed ID: 28643153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanized Anti-Tumor-Associated Glycoprotein-72 for Submillimeter Near-Infrared Detection of Colon Cancer in Metastatic Mouse Models.
    Hollandsworth HM; Amirfakhri S; Filemoni F; Hoffman RM; Molnar J; Yazaki PJ; Bouvet M
    J Surg Res; 2020 Aug; 252():16-21. PubMed ID: 32217350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody.
    Cox KE; Turner MA; Lwin TM; Amirfakhri S; Kelly KJ; Hosseini M; Ghosh P; Obonyo M; Hoffman RM; Yazaki PJ; Bouvet M
    Ann Surg Oncol; 2024 Sep; 31(9):6291-6299. PubMed ID: 38888861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
    Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging.
    Long NE; Sullivan BJ; Ding H; Doll S; Ryan MA; Hitchcock CL; Martin EW; Kumar K; Tweedle MF; Magliery TJ
    J Biol Chem; 2018 Jun; 293(23):9030-9040. PubMed ID: 29669811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models.
    Hollandsworth HM; Nishino H; Turner M; Amirfakhri S; Filemoni F; Hoffman RM; Yazaki PJ; Bouvet M
    In Vivo; 2020; 34(5):2303-2307. PubMed ID: 32871754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical characterization and in vivo imaging studies of an engineered recombinant technetium-99m-labeled metallothionein-containing anti-carcinoembryonic antigen single-chain antibody.
    Pietersz GA; Patrick MR; Chester KA
    J Nucl Med; 1998 Jan; 39(1):47-56. PubMed ID: 9443738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles.
    Girgis MD; Federman N; Rochefort MM; McCabe KE; Wu AM; Nagy JO; Denny C; Tomlinson JS
    J Surg Res; 2013 Nov; 185(1):45-55. PubMed ID: 23827791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.
    Lee SH; Jeung IC; Park TW; Lee K; Lee DG; Cho YL; Lee TS; Na HJ; Park YJ; Lee HG; Jeong MS; Bae KH; Lee SC; Lee HJ; Kwon YG; Hong HJ; Kim JS; Min JK
    Oncotarget; 2015 Mar; 6(9):7182-94. PubMed ID: 25762629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice.
    Zou P; Xu S; Povoski SP; Wang A; Johnson MA; Martin EW; Subramaniam V; Xu R; Sun D
    Mol Pharm; 2009; 6(2):428-40. PubMed ID: 19718796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Modular Dual-Labeling Scaffold That Retains Agonistic Properties for Somatostatin Receptor Targeting.
    Ghosh SC; Rodriguez M; Carmon KS; Voss J; Wilganowski NL; Schonbrunn A; Azhdarinia A
    J Nucl Med; 2017 Nov; 58(11):1858-1864. PubMed ID: 28572490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared-conjugated humanized anti-carcinoembryonic antigen antibody targets colon cancer in an orthotopic nude-mouse model.
    DeLong JC; Murakami T; Yazaki PJ; Hoffman RM; Bouvet M
    J Surg Res; 2017 Oct; 218():139-143. PubMed ID: 28985840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.
    Lwin TM; Minnix M; Li L; Sherman A; Hong T; Wong JYC; Olafsen T; Poku E; Bouvet M; Fong Y; Shively JE; Yazaki PJ
    Mol Imaging Biol; 2023 Aug; 25(4):727-734. PubMed ID: 37341873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological evaluation of 131I- and CF750-labeled Dmab(scFv)-Fc antibodies for xenograft imaging of CD25-positive tumors.
    Fan Q; Cai H; Yang H; Li L; Yuan C; Lu X; Wan L
    Biomed Res Int; 2014; 2014():459676. PubMed ID: 24864244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomolecular imaging of colorectal tumor lesions using a FITC-labeled scFv-Cκ fragment antibody.
    Kim HI; Kim J; Kim H; Lee H; Yoon YS; Hwang SW; Park SH; Yang DH; Ye BD; Byeon JS; Yang SK; Kim SY; Myung SJ
    Sci Rep; 2021 Aug; 11(1):17155. PubMed ID: 34433835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.
    Turner MA; Amirfakhri S; Nishino H; Lwin TM; Savides TJ; Reid TR; Singer BB; Hoffman RM; Bouvet M
    In Vivo; 2021; 35(4):1959-1963. PubMed ID: 34182469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humanized Anti-Carcinoembryonic Antigen Antibodies Brightly Target and Label Gastric Cancer in Orthotopic Mouse Models.
    Cox KE; Turner MA; Amirfakhri S; Lwin TM; Hosseini M; Ghosh P; Obonyo M; Murakami T; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2024 Jan; 293():701-708. PubMed ID: 37839102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction, affinity maturation, and biological characterization of an anti-tumor-associated glycoprotein-72 humanized antibody.
    Yoon SO; Lee TS; Kim SJ; Jang MH; Kang YJ; Park JH; Kim KS; Lee HS; Ryu CJ; Gonzales NR; Kashmiri SV; Lim SM; Choi CW; Hong HJ
    J Biol Chem; 2006 Mar; 281(11):6985-92. PubMed ID: 16407221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment.
    Willuda J; Honegger A; Waibel R; Schubiger PA; Stahel R; Zangemeister-Wittke U; Plückthun A
    Cancer Res; 1999 Nov; 59(22):5758-67. PubMed ID: 10582696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.